By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ardelyx Inc. 

34175 Ardenwood Boulevard
Suite 100
Fremont  California  94555  U.S.A.
Phone: 510-745-1700 Fax: n/a


Company News
Ardelyx Inc. (ARDX) Reports Fourth Quarter and Full Year 2014 Financial Results 2/26/2015 7:35:14 AM
Ardelyx Inc. (ARDX) To Report Fourth Quarter And Full Year 2014 Financial Results On February 25th, 2015 2/18/2015 12:57:28 PM
Ardelyx Inc. (ARDX) To Present At The 2015 Leerink Global Healthcare Conference 2/9/2015 11:53:09 AM
Ardelyx Inc. (ARDX) Reports Results from Phase 2b Clinical Trial Evaluating Tenapanor In Treating Hyperphosphatemia In Chronic Kidney Disease Patients On Hemodialysis 2/2/2015 9:23:31 AM
Ardelyx Inc. (ARDX) Appoints Jeremy S. Caldwell, Ph.D., As Executive Vice President And Chief Scientific Officer 12/1/2014 4:02:58 PM
Ardelyx Inc. (ARDX)'s Tenapanor Reduces Phosphorus Absorption And Protects Against Vascular Calcification In Preclinical In Vivo Model Of Chronic Kidney Disease 11/17/2014 3:26:38 PM
Ardelyx Inc. (ARDX) Reports Third Quarter 2014 Financial Results 11/6/2014 8:57:39 AM
Ardelyx Inc. (ARDX) To Report Third Quarter 2014 Financial Results On November 6, 2014 10/30/2014 9:36:19 AM
Ardelyx Inc. (ARDX)'s Tenapanor Selected For Oral And Poster Presentations At The American Society of Nephrology's Kidney Week 2014 10/23/2014 11:04:58 AM
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts 10/1/2014 3:14:37 PM